Loading...
ResMed Inc.
0KW4.L•LSE
Healthcare
Medical - Equipment & Services
£274.19
£-1.34(-0.49%)
ResMed Inc. (0KW4.L) Financial Performance & Income Statement Overview
Review ResMed Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.95%
↑ 10.95%
Operating Income Growth
16.61%
↑ 16.61%
Net Income Growth
13.75%
↑ 13.75%
Operating Cash Flow Growth
102.11%
↑ 102.11%
Operating Margin
32.75%
↑ 32.75%
Gross Margin
59.36%
↑ 59.36%
Net Profit Margin
27.22%
↑ 27.22%
ROE
25.51%
↑ 25.51%
ROIC
23.55%
↑ 23.55%
ResMed Inc. (0KW4.L) Income Statement & Financial Overview
Review ResMed Inc.'s (0KW4.L) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $1.29B | $1.28B | $1.22B | $1.22B |
| Cost of Revenue | $525.33M | $530.81M | $507.29M | $518.93M |
| Gross Profit | $766.41M | $751.27M | $717.22M | $704.26M |
| Gross Profit Ratio | $0.59 | $0.59 | $0.59 | $0.58 |
| R&D Expenses | $83.94M | $81.37M | $79.52M | $80.86M |
| SG&A Expenses | $245.30M | $241.61M | $238.98M | $242.19M |
| Operating Expenses | $340.14M | $334.03M | $329.91M | $323.05M |
| Total Costs & Expenses | $865.47M | $864.85M | $837.20M | $841.98M |
| Interest Income | $793000.00 | $0.00 | $0.00 | $3.63M |
| Interest Expense | $0.00 | $4.79M | $5.50M | $9.55M |
| Depreciation & Amortization | $51.91M | -$53.71M | $53.71M | $54.75M |
| EBITDA | $478.18M | $362.18M | $442.71M | $422.04M |
| EBITDA Ratio | $0.37 | $0.28 | $0.36 | $0.35 |
| Operating Income | $426.27M | $417.24M | $387.31M | $381.22M |
| Operating Income Ratio | $0.33 | $0.33 | $0.32 | $0.31 |
| Other Income/Expenses (Net) | -$8.57M | $1.08M | -$3.81M | -$23.48M |
| Income Before Tax | $417.69M | $418.32M | $383.50M | $357.73M |
| Income Before Tax Ratio | $0.32 | $0.33 | $0.31 | $0.29 |
| Income Tax Expense | $52.65M | $73.70M | $72.14M | $65.50M |
| Net Income | $365.04M | $344.62M | $311.36M | $292.24M |
| Net Income Ratio | $0.28 | $0.27 | $0.25 | $0.24 |
| EPS | $2.49 | $2.43 | $2.12 | $1.99 |
| Diluted EPS | $2.48 | $2.34 | $2.11 | $1.98 |
| Weighted Avg Shares Outstanding | $146.72M | $146.86M | $146.86M | $146.91M |
| Weighted Avg Shares Outstanding (Diluted) | $147.22M | $147.60M | $147.60M | $147.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan